Clinical Trial: Low Dose Atropine for Symptomatic Vitreous Floaters
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Vitreous Floaters
Study Type: INTERVENTIONAL
Official Title: Low Dose Atropine For Symptomatic Vitreous Floaters
Brief Summary:
The objective of this study is to identify a potential pharmacologic option by assessing whether 0.01% atropine may be effective for treating bothersome floaters as measured by scores on a modified NEI VFQ-25.
Read more